Xiaflex and Injection site bruising - a phase IV clinical study of FDA data

Summary:

Injection site bruising is found among people who take Xiaflex, especially for people who are male, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Xiaflex and have Injection site bruising. It is created by eHealthMe based on reports of 4,355 people who have side effects when taking Xiaflex from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 20, 2022

4,355 people reported to have side effects when taking Xiaflex.
Among them, 181 people (4.16%) have Injection site bruising.


What is Xiaflex?

Xiaflex has active ingredients of collagenase clostridium histolyticum. eHealthMe is studying from 3,704 Xiaflex users for its effectiveness, alternative drugs and more.

What is Injection site bruising?

Injection site bruising is found to be associated with 1,484 drugs and 947 conditions by eHealthMe.

Number of Xiaflex and Injection site bruising reports submitted per year:

Could Xiaflex cause Injection site bruising?

Time on Xiaflex when people have Injection site bruising *:

Click here to view

Gender of people who have Injection site bruising when taking Xiaflex*:

Click here to view

Age of people who have Injection site bruising when taking Xiaflex *:

Click here to view

Common drugs people take besides Xiaflex *:

Click here to view

Common side effects people have besides Injection site bruising *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Xiaflex and have Injection site bruising?

Check whether Injection site bruising is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Injection site bruising and when was it recovered:

Expand to all the drugs that have ingredients of collagenase clostridium histolyticum:

Alternative drugs to, pros and cons of Xiaflex:

Common Xiaflex side effects:

Browse all side effects of Xiaflex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Injection site bruising treatments and more:

COVID vaccines that are related to Injection site bruising:

Common drugs associated with Injection site bruising:

All the drugs that are associated with Injection site bruising:

Common conditions associated with Injection site bruising:

All the conditions that are associated with Injection site bruising:

How the study uses the data?

The study uses data from the FDA. It is based on collagenase clostridium histolyticum (the active ingredients of Xiaflex) and Xiaflex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: